STOCK TITAN

Sage Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Sage Therapeutics (NASDAQ: SAGE) has announced its participation in the 39th Annual J.P. Morgan Healthcare Conference, scheduled for January 12, 2021, at 10:50 a.m. ET. The event will be live-streamed on Sage's investor page, with a replay available for 30 days post-conference. Sage focuses on developing innovative therapies aimed at improving brain health for individuals facing severe brain disorders, including depression and neuropsychiatric conditions. The company aims to transform treatment approaches and enhance patient outcomes.

Positive
  • None.
Negative
  • None.

Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 10:50 a.m. ET.

A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will also be archived for up to 30 days on Sage's website following the conference.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

FAQ

When will Sage Therapeutics present at the J.P. Morgan Healthcare Conference?

Sage Therapeutics will present on January 12, 2021, at 10:50 a.m. ET.

How can I watch Sage Therapeutics' presentation at the conference?

A live webcast of Sage's presentation will be available on their investor page at investor.sagerx.com.

Is there a replay available for the Sage Therapeutics conference presentation?

Yes, a replay will be archived on Sage's website for up to 30 days after the conference.

What are the main focus areas of Sage Therapeutics?

Sage Therapeutics is focused on developing therapies for brain disorders, including depression and neuropsychiatry.

Sage Therapeutics, Inc

NASDAQ:SAGE

SAGE Rankings

SAGE Latest News

SAGE Stock Data

441.68M
53.83M
11.92%
80.97%
10.02%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE